Governance Loosens, Cancer Timelines Accelerate, and Dilution Hits Back

Individual stock stories dominated today’s action, with relaxed governance standards igniting a sharp rally, an accelerated cancer trial timeline lifting biotech sentiment, and new share offerings weighed on stocks facing dilution.

For decades, gold prices were suppressed to support a stronger U.S. dollar.

That grip loosened after a major bank was fined $920 million for manipulating gold.

Now, true price discovery is returning for the first time in more than half a century.

At the same time, a powerful new buyer is rapidly driving global gold demand higher.

See what’s driving gold now

Wall Street closed higher on Friday as softer job growth kept hopes for future rate cuts alive, while a rebound in chip stocks and relief over the Supreme Court delaying a tariffs ruling lifted risk appetite.

Amazon (NASDAQ: AMZN) is pushing deeper into healthcare by adding Novo Nordisk’s Wegovy pill to Amazon Pharmacy, and this move goes well beyond expanding a drug catalog.

Amazon is stepping directly into one of the fastest-growing areas of modern medicine and reshaping how patients enter treatment.

By offering the oral version of Wegovy, Amazon removes one of the biggest barriers to obesity care: injections.

If you have ever watched demand stall because treatment felt intimidating or complicated, you can see why this matters. Pills feel familiar, accessible, and easier to start.

Obesity Care Fits Amazon’s Muscle Memory

Weight management is not a one-time fix. It is recurring, long-term, and routine, exactly the kind of category Amazon knows how to scale.

Subscriptions, refills, delivery speed, and pricing clarity all play into Amazon’s strengths.

When you view healthcare as an increasingly consumer-style service, this move looks inevitable rather than bold.

One Ecosystem Starts to Lock In

Amazon is not stopping at delivery.

The company plans to offer Wegovy pills through prescription vending kiosks in select One Medical clinics, tying together pharmacy, primary care, and physical access.

Long term, this is about owning the rails of healthcare distribution. Wegovy is just the entry point.

The bigger signal is Amazon making itself unavoidable in how modern medicine gets delivered.

Compass (NYSE: COMP) has officially closed its acquisition of Anywhere Real Estate, locking in one of the most consequential consolidations the U.S. residential real estate industry has ever seen.

This merger unites the two largest residential brokerage platforms in the country. But this is not just about being bigger.

Compass is building a structural advantage at a moment when housing activity is uneven, margins are tight, and smaller players are feeling the squeeze.

Scale Stops Being Optional

By absorbing Anywhere’s brokerage brands, franchise network, and infrastructure, Compass dramatically expands its national footprint and agent density.

That concentration changes the math.

When agent recruiting, technology spend, and vendor pricing all benefit from size, you start to see why this deal hits harder in a slow market than a hot one.

Efficiency matters most when volume is scarce.

The Stack Gets Tighter

Compass has been clear about its ambition to control more of the residential transaction stack. This deal accelerates that push.

With more transactions flowing through one platform, Compass gains leverage with service partners and more room to invest in technology without blinking.

If you run a mid-sized brokerage, watching costs rise every year, the pressure just intensified. For Compass, this moment marks a shift.

Fast growth is giving way to structural dominance, and the competitive landscape just tilted in a way that will be felt across U.S. housing for years.

Liquidity is rising as the Fed shifts toward easier monetary policy.

Institutional capital continues flowing into crypto at record levels, while a pro-crypto administration accelerates favorable regulation.

Mid-term elections historically reward market-friendly policies—and after months of consolidation, conditions are aligning for a powerful move.

Nothing in crypto is ever guaranteed.

Crypto Revolution reveals a disciplined system for building crypto wealth without gambling, sleepless nights, or chasing every price swing.

Get instant access to the book plus $788 in bonuses now.

© 2026 Boardwalk Flock LLC. All Rights Reserved.

2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States

*The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.

*Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

Meta Platforms (NASDAQ: META) has made one of its most important long-range business decisions by locking in nuclear power as a core operating backbone.

Agreements with Oklo, TerraPower, and Vistra, layered on top of its earlier Constellation Energy deal, turn energy from a background cost into a strategic asset.

This is not about headlines or green branding. Meta needs massive, uninterrupted electricity to run data centers, train AI models, and support future platforms.

When compute never sleeps, you stop treating power like a utility and start treating it like infrastructure.

Always On Beats Flexible

Nuclear provides steady output without carbon pressure or weather risk.

By supporting both existing plants and next-generation builds, Meta secures reliability while helping projects cross financing hurdles that would stall without anchor customers.

Power Is Now a Growth Gate

These agreements give Meta access to multiple gigawatts over time. That scale is hard to overstate.

Competitors still rely on grids already under stress. Meta is building certainty.

In a world where AI expansion keeps colliding with power limits, you can see how this quietly widens the gap.

Control Changes the Conversation

There is also a signaling effect. Investing in domestic nuclear strengthens Meta’s position with regulators and policymakers and lowers reputational risk tied to rising energy use.

Energy becomes a controlled input rather than a bottleneck, and you do not need a crystal ball to see why that kind of durability matters when growth plans stretch decades forward.

👉 Click here to get our closing report to your cell for free!

Rich Sparkle Holdings Limited [ANPA] $86.85 (+258.88%)

Rich Sparkle jumped as the company opted out of certain Nasdaq governance requirements, giving it greater flexibility around future share issuances.

Cg Oncology Inc [CGON] $54.17 (+29.19%)

CG Oncology climbed after announcing its Phase 3 bladder cancer trial will report topline data nearly a year ahead of schedule.

Quanterix Corp [QTRX] $8.06 (+23.81%)

Quanterix advanced after appointing a seasoned commercial executive from Illumina as its next CEO, signaling a renewed growth push.

Beta Bionics Inc [BBNX] $20.14 (-37.04%)

Beta Bionics slipped despite strong preliminary sales growth as investors appeared to lock in gains ahead of full earnings and a February results call.

Flyexclusive Inc [FLYX] $6.37 (-11.89%)

flyExclusive fell after pricing a public stock offering at $6.65 per share, well below the prior day’s trading level, triggering dilution concerns.

The Greenbrier Companies, Inc [GBX] $47.75 (-10.48%)

Greenbrier dropped after quarterly results showed steep year-over-year declines in revenue and margins, overshadowing an earnings beat.

If you own ZERO of the Next Magnificent Seven stocks.

Original Mag Seven turned $7,000 into $1.18 million.

But these seven AI stocks could do it in 6 years (not 20).

Now, the man who called Nvidia in 2005 is revealing details on all seven for FREE.

Find Out More Now Before It's Too Late.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.